Ophthalmologic evaluation in patients undergoing immunization with melanoma-associated antigens. - Suppr | 超能文献

Ophthalmologic evaluation in patients undergoing immunization with melanoma-associated antigens.

作者信息

Kim C J, Chan C C, Rosenberg S A

出版信息

J Immunother. 1999 Mar;22(2):182-3. doi: 10.1097/00002371-199903000-00010.

DOI:10.1097/00002371-199903000-00010

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Ophthalmologic evaluation in patients undergoing immunization with melanoma-associated antigens.

J Immunother. 1999 Mar;22(2):182-3. doi: 10.1097/00002371-199903000-00010.

2

Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy.人类黑色素瘤抗原MART-1和gp100的免疫生物学及其在免疫基因治疗中的应用。

Int Rev Immunol. 1997;14(2-3):173-92. doi: 10.3109/08830189709116851.

3

Induction of strong and persistent MelanA/MART-1-specific immune responses by adjuvant dendritic cell-based vaccination of stage II melanoma patients.通过基于佐剂树突状细胞的疫苗接种对II期黑色素瘤患者诱导强烈且持久的MelanA/MART-1特异性免疫反应。

Int J Cancer. 2006 May 15;118(10):2617-27. doi: 10.1002/ijc.21679.

4

Immune selection after antigen-specific immunotherapy of melanoma.黑色素瘤抗原特异性免疫治疗后的免疫选择

Surgery. 1999 Aug;126(2):112-20.

5

Dendritic cells loaded with killed allogeneic melanoma cells can induce objective clinical responses and MART-1 specific CD8+ T-cell immunity.负载灭活同种异体黑色素瘤细胞的树突状细胞可诱导客观临床反应和MART-1特异性CD8 + T细胞免疫。

J Immunother. 2006 Sep-Oct;29(5):545-57. doi: 10.1097/01.cji.0000211309.90621.8b.

6

Peptide-specific CD8+ T-cell evolution in vivo: response to peptide vaccination with Melan-A/MART-1.体内肽特异性CD8 + T细胞的演变：对Melan-A/MART-1肽疫苗接种的反应。

Int J Cancer. 2002 Mar 20;98(3):376-88. doi: 10.1002/ijc.10165.

7

Stimulation of CD8+ T cell responses to MAGE-3 and Melan A/MART-1 by immunization to a polyvalent melanoma vaccine.通过接种多价黑色素瘤疫苗刺激CD8 + T细胞对MAGE - 3和黑色素A/MART - 1的反应。

Int J Cancer. 1997 Sep 17;72(6):972-6. doi: 10.1002/(sici)1097-0215(19970917)72:6<972::aid-ijc9>3.0.co;2-m.

8

Intralymphatic dendritic cell vaccination induces tumor antigen-specific, skin-homing T lymphocytes.淋巴内树突状细胞疫苗接种可诱导肿瘤抗原特异性、归巢至皮肤的T淋巴细胞。

Clin Cancer Res. 2006 Oct 1;12(19):5801-8. doi: 10.1158/1078-0432.CCR-05-2421.

9

Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization.转移性黑色素瘤患者的肽疫苗接种：在表现出有效免疫的患者中临床结局得到改善。

Am J Clin Oncol. 2006 Aug;29(4):352-60. doi: 10.1097/01.coc.0000217877.78473.a4.

10

Recognition of melanoma-derived antigens by CTL: possible mechanisms involved in down-regulating anti-tumor T-cell reactivity.细胞毒性T淋巴细胞对黑色素瘤衍生抗原的识别：下调抗肿瘤T细胞反应性的可能机制

Crit Rev Immunol. 1998;18(1-2):55-63. doi: 10.1615/critrevimmunol.v18.i1-2.70.

引用本文的文献

1

Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other".自身免疫与癌症免疫疗法：靶向“自身”以消灭“他者”。

Crit Rev Immunol. 2000;20(6):433-50.